Data Integrity: US FDA Guidance Seeks To Head Off Bioavailability/Bioequivalence Study Problems

Ultimate responsibility for data integrity rests with applicant, even if study is contracted out; testing site management should build a culture of quality, says the guidance, which aims to address the high-profile data integrity problems that have plagued the generic drug industry.